Remove AWS Remove Compliance Remove Pharmaceuticals
article thumbnail

Navigating the cloud maze: A 5-phase approach to optimizing cloud strategies

CIO

It prevents vendor lock-in, gives a lever for strong negotiation, enables business flexibility in strategy execution owing to complicated architecture or regional limitations in terms of security and legal compliance if and when they rise and promotes portability from an application architecture perspective.

Cloud 147
article thumbnail

The rise of the data lakehouse: A new era of data value

CIO

The giant pharmaceutical chain had put its lakehouse in place to address just such challenges in its quest, to, as Guadagno puts it, “To get the right product in the right place for the right patient.”. Moonfare selected Dremio in a proof-of-concept runoff with AWS Athena, an interactive query service that enables SQL queries on S3 data.

Data 210
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CIOs recalibrate multicloud strategies as challenges remain

CIO

The company’s recently announced plans to provide deep, seamless connectivity from Oracle Cloud Infrastructure to AWS , after similar announcements for Microsoft Azure and Google Cloud, have raised eyebrows. Bob McCowan, CIO of Regeneron Pharmaceuticals, says taking a cloud-native approach can help ease some multicloud challenges.

Strategy 193
article thumbnail

Ground truth generation and review best practices for evaluating generative AI question-answering with FMEval

AWS Machine Learning - AI

By segment, North America revenue increased 12% Y oY from $316B to $353B, International revenue grew 11% Y oY from$118B to $131B, and AWS revenue increased 13% Y oY from $80B to $91B. The template is compatible with and can be modified for other LLMs, such as LLMs hosted on Amazon Sagemaker Jumpstart and self-hosted on AWS infrastructure.

article thumbnail

CIOs weigh the new economics and risks of cloud lock-in

CIO

Caveat emptor in the cloud Bob McGowan, CIO of Regeneron Pharmaceuticals, acknowledges the risk of cloud concentration is valid but he is more concerned about the readiness of SaaS partners. “If It is no longer a decision between AWS and Azure. But] CIOs today have more choice in cloud providers than ever.

Cloud 197
article thumbnail

Deploy large language models for a healthtech use case on Amazon SageMaker

AWS Machine Learning - AI

In 2021, the pharmaceutical industry generated $550 billion in US revenue. Pharmaceutical companies sell a variety of different, often novel, drugs on the market, where sometimes unintended but serious adverse events can occur. We implemented the solution using the AWS Cloud Development Kit (AWS CDK).

article thumbnail

Highlights from AWS CEO Adam Selipsky’s Keynote at re:Invent

Perficient

To kick off the largest cloud conference of the year, Amazon Web Services (AWS) CEO Adam Selipsky delivered his opening keynote at AWS re:Invent in Las Vegas. Carrier saved 40% in costs by migrating to AWS Cloud. Selipsky welcomed 50,000 in-person attendees and 300,000 virtual attendees from around the globe.

AWS 64